Pennsylvania Study Of Chronic Obstructive Pulmonary Exacerbations

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1066 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-06-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The overall purpose of PA-SCOPE is to determine why black and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for chronic obstructive pulmonary disease (COPD)- and then to show that repeat acute exacerbations in high-risk patients can be reduced with one simple intervention. We believe that 1) COPD patients who are black or who live in rural areas of Pennsylvania are at higher risk of acute exacerbations requiring hospitalization and 2) this elevated risk can be reduced with one simple intervention: access to a 1-800 Temple Call Center where patients can get immediate customized advice on managing COPD exacerbations in their early stages. We will test these beliefs in PA-SCOPE. The collaborators with Temple University Hospital on the PA-SCOPE project are Lancaster General Hospital, Western Pennsylvania Hospital, and the Philadelphia College of Osteopathic Medicine.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry

NCT00540475

Idiopathic Pulmonary Fibrosis

COMPLETED

Predictors of Acute Exacerbation in Patients With COPD - an Observational Study

NCT04140097

Chronic Obstructive Pulmonary Disease COPD COPD Exacerbation +1 more

ACTIVE_NOT_RECRUITING

Biomarkers and Genetic Factors Related to Emphysema

NCT00757120

Emphysema Pulmonary Disease, Chronic Obstructive

COMPLETED

Study Assessing Utility of a Clinical Questionnaire to Identify Subjects With Features of Both Asthma and Chronic Obstructive Pulmonary Disease (COPD)

NCT02302417

Pulmonary Disease, Chronic Obstructive

COMPLETED PHASE2

Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific

NCT03151395

Respiratory Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* Overall objective: To determine why African American and rural residents of Pennsylvania might be at higher risk for deadly, debilitating, and costly hospitalizations for COPD-and to show that repeat acute exacerbations in high-risk patients can be reduced with one simple intervention--access to a 1-800 Temple Call Center phone number where patients can get immediate customized advice on managing COPD exacerbations in their early stages.
* Phase 1: To compare and contrast the influence of race and geographic location in COPD exacerbation in relation to severity, comorbidities, treatment patterns, infection rate. To identify potential risk factors for COPD exacerbations leading to hospitalization.
* Phase 2: To reduce hospitalizations and deaths due to COPD exacerbations and to improve patient quality of life, lung function, and everyday activity levels

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Phase 1 \& Gene Expression:Hospitalized COPD exacerbators

No interventions assigned to this group

2

Phase 2: COPD group

No interventions assigned to this group

3

Genetic Association Studies: COPD and Healthy Controls

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Phase 1 \& Gene Expression: --Current hospitalization for COPD exacerbation
* Phase 1 \& 2: COPD \& ONE of the following criteria:

1. History of hospitalization for COPD exacerbation, OR
2. Currently on supplemental oxygen, OR
3. History of evaluation for lung transplant or LVRS, OR
4. \>/= 6 months post-LVRS
* Phase 1 or 2:

1. Current or former smoker, \>/= 20 pack-yr. smoking history
2. FEV1 \</= 70%; FEV1/FVC \</= 70%
3. Life expectancy of \> 6 months

Exclusion Criteria

* \< 20 pack-yr. smoking history
* Diagnosis of pulmonary fibrosis, bronchiectasis, mediastinal mass, or presence of a pulmonary mass
* Asthma
* FEV1 \> 70% or FEV1/FVC \>70%

Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes